How COVID-19 stimulus packages are affecting the Australian economy

Published 24-JUL-2020 12:51 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Many Australian’s are currently enjoying the benefits of the Governments COVID-19 stimulus measures, although there are just as many worrying about the debt we are creating as a nation and how we will survive this.

On Thursday, Treasurer Josh Frydenberg revealed that Australia’s budget would blow out to $184.5 billion over the next year, making it the biggest deficit we have experienced since World War II and putting Australia further into debt. While increasing our national debt should be concerning to all Australians, we also need to look at the bigger picture and put what is now happening into context.

In 2019, Australia’s debt to GDP was 41.80 percent and after Thursday’s announcement this will rise even further. By how much is uncertain right now, although expectations are that it will not be an alarming increase. In comparison, if we look at US debt, we see that the debt to GDP is currently sitting at a massive 132.57 percent. To see the US debt to GDP level like Australia is currently experiencing, you have to go back 60 years to the 1960s when the US debt to GDP ratio was 52.65 percent.

Much of the growth in debt in Australia has occurred over the last decade because in 2000, at the height of the GFC bull run, the debt to GDP level was just 9.7 percent. When you compare that to today's level, you can start to understand why so many Australians are currently concerned. Stimulus packages during the GFC also saw debt levels in the US increase significantly but unlike the US, Australia has done an excellent job over the past four years in curbing its debt to GDP level, as it has been in the low 40 percent range since 2016 and, until COVID-19, was set to fall away.

So, should we be concerned?

Like so many others, I am concerned but I am not alarmed by our debt levels for two reasons. The first is that a nation’s debt is very different to household debt, because unlike individuals who have set periods as to when the debt must be repaid, the nation's debt has no set time limits. Secondly, our debt to GDP level is currently quite acceptable and, as a nation, we are much better placed than most other countries to not only handle this increased debt but also thrive over the next few years.

Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also the author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in bookstores and online at www.wealthwithin.com.au



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X